The Syn-D study: detection of cutaneous phosphorylated alpha-synuclein in mild cognitive impairment a trial protocol

Authors

Institutions

Publication Details

Journal
Biomarkers in Medicine
Published
2025-06-16
DOI
https://doi.org/10.1080/17520363.2025.2520154
Citations
1
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
1.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Syn-D study: detection of cutaneous phosphorylated alpha-synuclein in mild cognitive impairment a trial protocol

Roy Freeman, Daniel O. Claassen, Douglas R Galasko, Daniel Z. Press et al.
1 citations
Biomarkers in Medicine
Parkinson's Disease Mechanisms and Treatments
1.39
article

The Syn-D study: detection of cutaneous phosphorylated alpha-synuclein in mild cognitive impairment a trial protocol

Roy Freeman, Daniel O. Claassen, Douglas R Galasko, Daniel Z. Press, Christopher H. Gibbons, Todd Levine
article en
1 citations

Abstract

No abstract available for this paper.
Biomarkers in MedicineVol. 19(13)
Harvard University (US), Vanderbilt University (US), University of California System (US)
National Institute on Aging
Openalex Percentile: Top 19%
Parkinson's Disease Mechanisms and Treatments
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.